Helping Togolese women plan and space their pregnancies since 1989.
- Postpartum intrauterine device (PPIUD) services are now available at 50 health care facilities in Togo, with providers ready to meet the needs of postpartum women in surrounding areas.
- More than 200 providers have been trained to provide accurate and appropriate information on postpartum family planning, including PPIUDs, to pregnant women and can refer them to a health care facility where these services are provided if they are not available at their own site.
- More than 2,510 PPIUDs have been inserted at Jhpiego-supported health care facilities for postpartum women seeking to delay their next pregnancy.
Our Work in Togo
Under the Maternal and Child Survival Program, funded by the U.S. Agency for International Development, Jhpiego is supporting the development of a national scale-up plan for postpartum family planning and activities to promote male engagement in family planning. These activities include: 1) a rapid formative assessment on male engagement in the health of their families, 2) the development of a social and behavior change strategy to enhance the engagement of men in their families’ reproductive health, and 3) discrete activities to promote this strategy, in collaboration with the Ministry of Health and other implementing partners.
With funding from Family Planning 2020’s Rapid Response Mechanism, Jhpiego is supporting the Ministry of Health’s Department of Family Health to introduce, learn from and scale up subcutaneous depot-medroxyprogesterone acetate (DMPA-SC) in two health districts. DMPA-SC is an innovative injectable contraceptive—also known as Sayana® Press—that can dramatically expand access and choice for women who want to use contraception. Under this project, Jhpiego and the Department of Family Health are building the capacity of facility-based health care providers and community-based health workers to provide DMPA-SC and introduce two approaches for the provision of DMPA-SC in districts where intramuscular DMPA is not available. In Kloto, the project is introducing community-based distribution of DMPA-SC by community health workers; in Gulf, the focus is on facility-based providers supporting clients to self-inject DMPA-SC. The project will document learning from these two approaches to support the Department of Family Health to rapidly scale up DMPA-SC across Togo.
Funded by the Bill & Melinda Gates Foundation, this program promotes access to family planning choices in West African countries by supporting the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is an innovative injectable contraceptive—also known as Sayana® Press—that can dramatically expand access and choice for women. Jhpiego is enhancing ongoing efforts of the Access Collaborative by strengthening health systems to accelerate introduction and scale-up of DMPA-SC in several West African countries, including Togo.